2022
Incidence, survival, and prognostic factors associated with malignant nodular hidradenoma in the United States
Ugwu N, Cheraghlou S, Ko CJ, Cohen JM. Incidence, survival, and prognostic factors associated with malignant nodular hidradenoma in the United States. Journal Of The American Academy Of Dermatology 2022, 88: 875-877. PMID: 36228937, DOI: 10.1016/j.jaad.2022.09.053.Peer-Reviewed Original Research
2020
Primary cutaneous adenoid cystic carcinoma: Characterizing US demographics, clinical course, and prognostic factors
Yumeen S, Mirza FN, Mirza HN, Ko CJ, Cohen JM. Primary cutaneous adenoid cystic carcinoma: Characterizing US demographics, clinical course, and prognostic factors. Journal Of The American Academy Of Dermatology 2020, 85: 245-247. PMID: 32798575, DOI: 10.1016/j.jaad.2020.08.040.Peer-Reviewed Original Research
2015
Risk stratification in extramammary Paget disease
Cohen JM, Granter SR, Werchniak AE. Risk stratification in extramammary Paget disease. Clinical And Experimental Dermatology 2015, 40: 473-478. PMID: 26011765, DOI: 10.1111/ced.12690.Peer-Reviewed Original ResearchConceptsExtramammary Paget's diseaseRisk stratificationPaget's diseaseUncommon intraepithelial adenocarcinomaImportant prognostic informationDepth of invasionIntraepithelial adenocarcinomaPatient ageExtracutaneous sitesLymph nodesPrognostic factorsPoor prognosisMucin 5ACPrognostic informationKi-67Perianal regionHigh riskLesion siteClinical practiceApocrine glandsBody sitesTumor geneticsReticular dermisCyclin D1Treatment planning